Healthpeak Properties Inc. Stock Rises Tuesday, Still Underperforms Market
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Hold Rating, Maintains Target Price $23.5
Analysts Conflicted on These Real Estate Names: Starwood Property (STWD) and Healthpeak Properties (DOC)
Raymond James Initiates Healthpeak Properties(DOC.US) With Hold Rating
Raymond James Keeps Their Hold Rating on Healthpeak Properties (DOC)
Real Estate Stocks Continue to Fall Ahead of the December FOMC Meeting
Healthpeak Properties Is Maintained at Equal-Weight by Wells Fargo
Healthpeak Properties Analyst Ratings
HealthPeak Boosts Flexibility With $3B Revolving Credit Facility
Wells Fargo Maintains Healthpeak Properties(DOC.US) With Hold Rating, Cuts Target Price to $22
Express News | Healthpeak Properties Extends Its $3 Billion Revolving Credit Facility
Stocks With Best Odds of Risk-adjusted Returns Deserve Attention: Goldman Sachs
Mizuho Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Announces Target Price $24
Mizuho Maintains Outperform on Healthpeak Properties, Lowers Price Target to $24
Price Over Earnings Overview: Healthpeak Properties
High-Yield REITs To Watch: Three Wall Street-Approved S&P 500 Gems
Real Estate Stocks Rebound on Segment Gains, Trump Picks for Housing
Balanced Outlook: Healthpeak Properties' Strong Performance Amid Market Headwinds
Healthpeak Properties Sees 2024 Total Merger-Combined Same-Store Cash (Adjusted) NOI Growth 4% - 5% >DOC
Press Release: Healthpeak Properties Raises 2024 Guidance